|
Shtutman, Michael; Maliyekkel, Anil; Shao, Yu et al. (2010) Function-based gene identification using enzymatically generated normalized shRNA library and massive parallel sequencing. Proc Natl Acad Sci U S A 107:7377-82
|
|
Chan, Chi Yu; Carmack, C Steven; Long, Dang D et al. (2009) A structural interpretation of the effect of GC-content on efficiency of RNA interference. BMC Bioinformatics 10 Suppl 1:S33
|
|
Yates, Kristin E; Korbel, Gregory A; Shtutman, Michael et al. (2008) Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts. Aging Cell 7:609-21
|
|
Broude, Eugenia V; Demidenko, Zoya N; Vivo, Claire et al. (2007) p21 (CDKN1A) is a negative regulator of p53 stability. Cell Cycle 6:1468-71
|
|
Broude, E V; Swift, M E; Vivo, C et al. (2007) p21(Waf1/Cip1/Sdi1) mediates retinoblastoma protein degradation. Oncogene 26:6954-8
|
|
Shao, Yu; Chan, Chi Yu; Maliyekkel, Anil et al. (2007) Effect of target secondary structure on RNAi efficiency. RNA 13:1631-40
|
|
Barre, Benjamin; Vigneron, Arnaud; Perkins, Neil et al. (2007) The STAT3 oncogene as a predictive marker of drug resistance. Trends Mol Med 13:4-11
|
|
Chen, Yuhong; Dokmanovic, Milos; Stein, Wilfred D et al. (2006) Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells. Cancer Res 66:8749-61
|
|
Davidovich, Irina A; Levenson, Anait S; Levenson Chernokhvostov, Victor V (2004) Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance. Cancer Lett 211:189-97
|
|
Shay, Jerry W; Roninson, Igor B (2004) Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23:2919-33
|
Showing the most recent 10 out of 34 publications
